The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2025Clinical Development of 18F-RO7196581:A High-resolution PET Imaging Study Using NeuroExplorer
Study Rationale: The primary objective of this study is to assess the feasibility and effectiveness of high-resolution PET imaging using the NeuroExplorer to visualize alpha-synuclein aggregation in...
-
Research Grant, 2025From Omics to Action: A Multimodal Pipeline for Druggable Target Discovery and Real-world Validation in PD
Study Rationale: Parkinson’s disease (PD) affects millions of people and currently has no treatment that can slow or stop its progression. While large genetic and molecular studies have uncovered many...
-
Research Grant, 2025Knowledge of Parkinson’s Disease and Impact of an Educational Intervention in the Somali Community in King County
Study Rationale: Parkinson’s disease (PD) affects more than 10 million people worldwide, including one million in the U.S., with an incidence of 1% among individuals over 60. Although prevalence is...
-
Research Grant, 2025Click Chemistry-based Alpha-synuclein PET Biomarker Discovery
Study Rationale: In Parkinson’s disease (PD) and related disorders, a protein called alpha-synuclein (asyn) forms harmful deposits in the brain. Doctors can’t see these changes in living people...
-
Research Grant, 2025Planning for a LRRK2 Platform Trial
Study Rationale: The therapeutic landscape for LRRK2-related Parkinson’s disease (LRRK2-PD) is rapidly evolving, creating an urgent need to evaluate emerging treatments. Given the distinct clinical...
-
Summer 2025 RFA: Personalized Approaches for Understanding, Assessing and Improving Gait in Parkinson’s Disease Research Program, 2026Sensing-Enabled Directional Deep Brain Stimulation of the Cuneiform Nucleus for Levodopa-Resistant Freezing of Gait in Parkinson’s Disease
Study Rationale:
Freezing of gait (FOG) is one of the most disabling symptoms of Parkinson’s disease. People with FOG may suddenly feel like their feet are “stuck” to the ground, especially when...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.